Yes. With surgical sperm retrieval techniques such as TESA or Micro-TESE, sperm can be extracted directly from the testicle in most azoospermic men and used successfully in ICSI to achieve fertilization and pregnancy. Extensive research spanning three decades confirms that children born through ICSI have fully comparable developmental, cognitive, and physical health outcomes to naturally conceived children, with no increased long-term health risks from the procedure itself.

ICSI fertilization rates typically range from 60% to 80% per injected egg. Overall pregnancy success rates per transfer depend on factors including the woman's age, embryo quality, and uterine health, typically ranging from 40% to 60% per cycle in good-prognosis patients. Many couples achieve success in 1 to 3 ICSI cycles. The number needed depends on the woman's age, embryo quality, the severity of male infertility, and the uterine environment. Your specialist will review each cycle and refine the protocol accordingly.

The main risks include Ovarian Hyperstimulation Syndrome (OHSS) from stimulation medications, a small risk of egg damage during microinjection (5 to 10% of eggs), failed fertilization despite precise injection, and multiple pregnancy if more than one embryo is transferred. At Galwa Care Hospital, these risks are significantly minimized through individualized stimulation dosing, strict cycle monitoring protocols, experienced embryology, and a strong preference for single embryo transfer in appropriate cases to reduce multiple pregnancy risk.

Yes. All surplus good-quality embryos produced during an ICSI cycle can be vitrified (flash-frozen) and stored securely at Galwa Care Hospital for future frozen embryo transfer (FET) cycles. This significantly improves the overall cost-efficiency and cumulative success of the treatment by giving couples additional transfer opportunities from a single stimulation cycle without the need to repeat the entire process from the beginning.